FI960260A0 - Kondenserat bensazepinderivat och dess farmaceutiska komposition - Google Patents

Kondenserat bensazepinderivat och dess farmaceutiska komposition

Info

Publication number
FI960260A0
FI960260A0 FI960260A FI960260A FI960260A0 FI 960260 A0 FI960260 A0 FI 960260A0 FI 960260 A FI960260 A FI 960260A FI 960260 A FI960260 A FI 960260A FI 960260 A0 FI960260 A0 FI 960260A0
Authority
FI
Finland
Prior art keywords
pharmaceutical mixture
benzazepine derivative
condensed benzazepine
condensed
derivative
Prior art date
Application number
FI960260A
Other languages
English (en)
Finnish (fi)
Other versions
FI960260A (sv
FI113178B (sv
Inventor
Akihiro Tanaka
Hiroyuki Koshio
Nobuaki Taniguchi
Akira Matsuhisa
Ken-Ichiro Sakamoto
Atsuki Yamazaki
Takeyuki Yatsu
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of FI960260A0 publication Critical patent/FI960260A0/sv
Publication of FI960260A publication Critical patent/FI960260A/sv
Application granted granted Critical
Publication of FI113178B publication Critical patent/FI113178B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Output Control And Ontrol Of Special Type Engine (AREA)
FI960260A 1993-07-21 1996-01-19 Förfarande för framställning av ett terapeutiskt värdefull 5,6-dihydro-4H-tiazolo[5,4-d]-, -oxazolo[4,5-d]- eller -imidazo[4,5-d][1]-benzazepin-6-fenylkarbonylderivat FI113178B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP18043593 1993-07-21
JP18043593 1993-07-21
PCT/JP1994/001183 WO1995003305A1 (fr) 1993-07-21 1994-07-19 Derive de benzazepine de fusion et composition pharmaceutique renfermant ce derive
JP9401183 1994-07-19

Publications (3)

Publication Number Publication Date
FI960260A0 true FI960260A0 (sv) 1996-01-19
FI960260A FI960260A (sv) 1996-01-19
FI113178B FI113178B (sv) 2004-03-15

Family

ID=16083198

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960260A FI113178B (sv) 1993-07-21 1996-01-19 Förfarande för framställning av ett terapeutiskt värdefull 5,6-dihydro-4H-tiazolo[5,4-d]-, -oxazolo[4,5-d]- eller -imidazo[4,5-d][1]-benzazepin-6-fenylkarbonylderivat

Country Status (18)

Country Link
US (2) US5723606A (sv)
EP (2) EP1097920B1 (sv)
KR (1) KR100304331B1 (sv)
CN (1) CN1040210C (sv)
AT (2) ATE277003T1 (sv)
AU (2) AU683483B2 (sv)
CA (1) CA2167673C (sv)
DE (2) DE69434032T2 (sv)
ES (2) ES2198418T3 (sv)
FI (1) FI113178B (sv)
HU (1) HUT74582A (sv)
NO (1) NO306303B1 (sv)
NZ (1) NZ268671A (sv)
PL (1) PL177738B1 (sv)
RU (1) RU2129123C1 (sv)
TW (1) TW279163B (sv)
UA (1) UA64690C2 (sv)
WO (1) WO1995003305A1 (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760031A (en) * 1993-07-29 1998-06-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5693635A (en) * 1993-07-29 1997-12-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AR002459A1 (es) * 1995-01-17 1998-03-25 American Cyanamid Co Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
CA2319649A1 (en) 1998-01-28 1999-08-05 Mitsunori Waki Preventives or remedies for vision disorders
AR018818A1 (es) * 1998-04-03 2001-12-12 Yamano Masaki Una composicion farmaceutica para la terapia de un edema.
AU4168999A (en) * 1998-06-19 2000-01-05 Wakamoto Pharmaceutical Co., Ltd. Ocular tension lowering agents and phosphoric ester derivatives
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
US6765004B1 (en) * 1999-06-17 2004-07-20 Ortho-Mcneil Pharmaceutical, Inc. Indoloazepines as vasopressin receptor antagonists
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
WO2001054698A1 (en) * 2000-01-26 2001-08-02 Warner-Lambert Company Method for preventing or treating postoperative ileus
BR0017074A (pt) * 2000-01-26 2002-12-03 Warner Lambert Co Combinações de inibidor de ace-antagonista de vasopressina
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) * 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
AU779929B2 (en) * 2000-10-04 2005-02-17 Warner-Lambert Company Treatment of pulmonary hypertension
ATE367815T1 (de) 2000-10-04 2007-08-15 Astellas Pharma Inc Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension
WO2002044179A1 (fr) * 2000-11-28 2002-06-06 Yamanouchi Pharmaceutical Co., Ltd. Dérivés de 1,4,5,6-tétrahydroimidazo[4,5-d]diazépine ou sels de ces derniers
CA2856037C (en) * 2005-12-28 2017-03-07 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
US20080221084A1 (en) * 2006-10-30 2008-09-11 Otsuka Pharmaceutical Co., Ltd. Method for reducing infarction using vasopressin antagonist compounds, and compositions and combinations therefor
US20090069295A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched conivaptan
CA2711644A1 (en) * 2008-01-07 2009-07-16 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
WO2009102761A1 (en) * 2008-02-12 2009-08-20 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
MX2010013920A (es) * 2008-06-26 2011-02-21 Amgen Inc Alcoholes alquinilicos como inhibidores de cinasas.
WO2011052519A1 (ja) * 2009-10-26 2011-05-05 大塚製薬株式会社 ベンズアゼピン化合物
US20150238502A1 (en) 2012-10-18 2015-08-27 University Of South Florida Compositions and Methods for Treating Stroke
CN103497195B (zh) * 2013-10-21 2016-01-27 北京科莱博医药开发有限责任公司 盐酸考尼伐坦新晶型及其制备方法
CN105310978A (zh) * 2014-08-04 2016-02-10 李峰 一种含有活性成分盐酸考尼伐坦的药物组合物及其制剂
CN105884778A (zh) * 2014-09-24 2016-08-24 李峰 一种化合物和制备方法
CN105153168A (zh) * 2015-09-29 2015-12-16 上海天慈国际药业有限公司 N-[4-(2-甲基-4,5-二氢-3H-咪唑并[4,5-d][1]苯并氮杂卓-6-甲酰基)苯基]-2-苯基苯甲酰胺盐酸盐的制备方法
CN106317060B (zh) * 2016-08-22 2019-02-15 山东罗欣药业集团恒欣药业有限公司 一种盐酸考尼伐坦的制备方法
WO2019036024A1 (en) 2017-08-17 2019-02-21 Bristol-Myers Squibb Company 2- (1,1'-BIPHENYL) -1H-BENZO [D] IMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS AGONISTS OF APELIN AND APJ FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
CN116472271A (zh) * 2020-11-26 2023-07-21 上海济煜医药科技有限公司 新型苯并氮杂卓螺环衍生物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011628A (en) * 1988-06-15 1991-04-30 Givaudan Corporation N,N'-diarylbenzamidines useful as ultraviolet light absorbers
SG28353G (en) * 1988-06-15 1995-09-18 Givaudan Roure Int Benzamidines useful as ultraviolet light absorbers
US5225402A (en) * 1989-02-10 1993-07-06 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
EP0450097B1 (en) * 1989-10-20 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
JP2905909B2 (ja) * 1991-04-19 1999-06-14 大塚製薬株式会社 バソプレシン拮抗剤
JPH03255077A (ja) * 1990-03-01 1991-11-13 Taiji Nakayama ピリミジン誘導体およびそれを有効成分とする血小板凝集阻止剤
CA2066104C (en) * 1991-04-19 2003-05-27 Hidenori Ogawa Benzazepine derivatives as vasopressin antagonists
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
JP3255077B2 (ja) * 1997-04-23 2002-02-12 日本電気株式会社 電話機

Also Published As

Publication number Publication date
ATE239726T1 (de) 2003-05-15
DE69434032D1 (de) 2004-10-28
FI960260A (sv) 1996-01-19
RU2129123C1 (ru) 1999-04-20
HUT74582A (en) 1997-01-28
NO960231D0 (no) 1996-01-19
CN1040210C (zh) 1998-10-14
EP0709386A4 (en) 1997-06-25
DE69432632D1 (de) 2003-06-12
UA64690C2 (en) 2004-03-15
EP0709386B1 (en) 2003-05-07
EP1097920B1 (en) 2004-09-22
AU683483B2 (en) 1997-11-13
CA2167673C (en) 2004-09-21
TW279163B (sv) 1996-06-21
ES2228405T3 (es) 2005-04-16
NO306303B1 (no) 1999-10-18
EP1097920A1 (en) 2001-05-09
AU7195794A (en) 1995-02-20
AU3990697A (en) 1997-12-18
EP0709386A1 (en) 1996-05-01
ATE277003T1 (de) 2004-10-15
ES2198418T3 (es) 2004-02-01
HU9600102D0 (en) 1996-03-28
DE69434032T2 (de) 2005-09-22
DE69432632T2 (de) 2004-02-19
US5723606A (en) 1998-03-03
FI113178B (sv) 2004-03-15
CA2167673A1 (en) 1995-02-02
CN1127508A (zh) 1996-07-24
KR100304331B1 (ko) 2001-11-22
PL312654A1 (en) 1996-04-29
NZ268671A (en) 1997-09-22
PL177738B1 (pl) 2000-01-31
US5856564A (en) 1999-01-05
NO960231L (no) 1996-03-21
KR960703917A (ko) 1996-08-31
WO1995003305A1 (fr) 1995-02-02

Similar Documents

Publication Publication Date Title
FI960260A0 (sv) Kondenserat bensazepinderivat och dess farmaceutiska komposition
DK139588A (da) Benzodiazepinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
NZ234327A (en) Quinazoline derivatives and pharmaceutical compositions
DK287285D0 (da) Benzodiazepinderivat og farmaceutisk praeparat indeholdende et saadant derivat
DE69021618D1 (de) Antagonisten von exzitatorischen Aminosäuren.
ATE175966T1 (de) Ace-hemmer die ein kondensiertes polycyclisches- lactam enthalten
DK0595610T3 (da) Benzokondenserede lactamer
UY24625A1 (es) Derivados de la 4-hidroxi-piperidina
MX9201356A (es) Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BG104740A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
NO932517L (no) 5,10-metylentetrahydrofolsyre-syklo-dekstrin-inkulusjonsforbindels er
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FI921576A0 (fi) Kolecystokininantagonister.
NO923266L (no) Heksahydrobenzo(f)quinolinoner
DE68914545D1 (de) Peptid-Derivate und Wirkstoffe gegen Dementia.
ES2091570T3 (es) Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NZ238124A (en) Heterocyclylalkylphosphonic acid and ester derivatives and pharmacueitcal compositions
CA2453123A1 (en) Intermediate for condensed benzazepine derivatives
ES2070962T3 (es) N-hidroxi-dibenzo(b,e)oxepin-alquilaminas y -amidas de acido alcanoico, compuestos analogos heterociclicos relacionados, un procedimiento para su preparacion y su uso en la preparacion de medicamentos.
ES2134879T3 (es) Metalocenos que contienen compuestos de fluorenilo sustituidos en la posicion 9 y uso de los metalocenos.
ATE154927T1 (de) Synthese von tricyclo (3.3.1.13,7>dec-2-yl r-
ECSP972237A (es) Derivados de 6,5 heterobiciclicos sustituidos

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ASTELLAS PHARMA INC.

Free format text: ASTELLAS PHARMA INC.